Given the inherent mesenchymal phenotype of triple negative breast cancer cells, we determined the expression of the mesenchymal marker vimentin and the epithelial marker E-cadherin in relation to PRAME expression (Fig. 5a). The gene discussed is CDH1; the disease is triple-negative breast carcinoma.